secwatch.observer — SEC 8-K summary
======================================

Issuer:     NantHealth, Inc. (—)
CIK:        0001566469
Form:       8-K
Filed at:   2023-09-13T23:59:59+00:00
Accession:  0001566469-23-000059
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

NantHealth appoints Rao Haris Naseem as CEO; Patrick Soon-Shiong remains Chairman
--------------------------------------------------------------------------------

- Dr. Rao Haris Naseem appointed CEO and board member effective September 7, 2023.
- Founder Patrick Soon-Shiong steps down as CEO but continues as Chairman.
- Base salary set at $35,568; eligible for discretionary bonus; option to purchase 1,000,000 shares subject to board approval.
- Naseem's affiliate Summus Holdings purchased 3,846,154 shares ($1.5M) in a private placement closed August 30, 2023.
- Employment is at-will; vesting of stock options accelerated 100% upon change in control.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/0001566469-23-000059-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1566469/000156646923000059/nh-20230907.htm
  HTML page:      https://secwatch.observer/filing/0001566469-23-000059

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer